Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Grant or award Principal Accounting Officer acquired 3,837 shares (grant or award)
  2. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $34.98 ($349,800)
  3. 3 Insider Initial Statement of Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Executive or director change
  6. 4 Open-market sale Chief Scientific Officer sold 11,200 shares at an average $33.71 ($377,561)
  7. 4 Open-market sale Chief Operating Officer sold 3,125 shares at an average $33.16 ($103,630)
  8. 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $32.95 ($385,018)
  9. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $32.41 ($324,050)
  10. 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $36.98 ($432,054)
  11. 4 Open-market sale CEO and Chairman sold 43,499 shares at an average $38.43 ($1,671,496)
  12. 4 Open-market sale Chief Financial Officer sold 14,375 shares at an average $39.47 ($567,331)
  13. 4 Open-market sale SVP and General Counsel sold 495 shares at $40.00 ($19,800)
  14. 4 Open-market sale Director sold 14,916 shares at $35.00 ($522,060)
  15. 4 Open-market sale Chief Scientific Officer sold 11,685 shares at an average $34.25 ($400,231)
  16. 4 Grant or award Chief Commercial Officer acquired 97,213 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $34.07 ($511,049)
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 21 of 42 · 837 filings